COLOGNE, GERMANY and PHILADELPHIA, PA / ACCESSWIRE / February 2, 2021 / CEVEC Pharmaceuticals GmbH (CEVEC) and CARISMA Therapeutics Inc. (CARISMA) today announced the signing of an agreement which ...

COLOGNE, GERMANY / ACCESSWIRE / February 9, 2017 / CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced ...

Cologne, Germany, December 21, 2010 / b3c newswire / - CEVEC Pharmaceuticals, the developer of the CAP® protein expression system derived from human amniocytes, today announced that Rainer Christine ...

ELEVECTA(R) takes viral vector manufacturing to the next level to serve the rapidly growing market of gene therapy applications Growing serum-free in suspension, ELEVECTA(R) producer cell lines enable ...

Cologne, Germany, May 26, 2010 / b3c newswire / - CEVEC Pharmaceuticals, the German developer of a novel human expression system derived from amniocytes, announced today the signing of an exclusive ...

CEVEC Pharmaceuticals has announced its new management team: Wolfgang Kintzel remains Chief Executive Officer, Dr. Nicole Faust is appointed Chief Scientific Officer, Dr. Hartmut Tintrup is appointed ...

The new cell-line producing platform enables fully scalable production of high-performance adeno-associated virus vectors. On April 28, 2020, Cevec Pharmaceuticals announced the launch of the ELEVECTA ...

Jed Seifert says his greatest moment of last year was the day he walked into Stakes Manufacturing in Eastlake to see an older couple he didn’t recognize. After introductions were made, Seifert learned ...

DJ CEVEC raises EUR4M to finance strong growth of human CAP® technology CEVEC raises EUR4M to finance strong growth of human CAP® technology =----- Cologne, Germany, November 03, 2009 / b3c ...